Related Experiment Video
Updated: Feb 18, 2026

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis
Published on: October 6, 2023
Routine Use of Quantitative Disease Activity Measurements among US Rheumatologists: Implications for Treat-to-target
Jeffrey R Curtis1,2, Lang Chen3,4, Maria I Danila3,4
1From University of Alabama at Birmingham, Birmingham, Alabama; Baylor Research Institute, Dallas, Texas, USA. jrcurtis@uabmc.edu.
Objective:
The aim of our study was to examine why real-world practices and attitudes regarding quantitative measurements of rheumatoid arthritis (RA) have received limited attention.
Methods:
An e-mail survey asked US rheumatologists to self-report on their use of quantitative measurements (metric).
Results:
Among 439 respondents, metric rheumatologists (58%) were more likely to be in group practice and to use tumor necrosis factor inhibitors. The quantitative tools most commonly used were the Health Assessment Questionnaire (35.5%) and the Routine Assessment of Patient Index Data 3 (27.1%). Reasons for not measuring included time needed and electronic availability. Based on simulated case scenarios, providing more quantitative information increased the likelihood that a patient would change to a different disease-modifying antirheumatic drug or biologic.
Conclusion:
Routine use of quantitative measurement for patients in the United States with RA is increasing over time but remains low.
More Related Videos
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Rheumatic Heart Disease III: Medical Management
Therapeutic Drug Monitoring: Overview and Classification
Rheumatic Heart Disease IV: Nursing Management
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Therapeutic Drug Monitoring: Drug Analysis Methods

